CITALOPRAM Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Most common reason: Chemical / undeclared (3 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Citalopram. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
Lack of Processing Controls
Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Labeling:Label Mixup; CITALOPRAM Tablet, 10 mg may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: AD52778_61, EXP: 5/20/2014; COENZYME Q-10, Capsule, 30 mg, NDC 00904501546, Pedigree: W002814, EXP: 6/7/2014.
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.